Recent research have focused on the intersection Retatrutide of GLP|GIP|GCGR activator therapies and dopaminergic neurotransmission. While GLP agonists are increasingly employed for treating type 2 diabetes, their emerging consequences on motivation circuits, specifically influenced by dopamine sys… Read More